Francesca Bruce
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Francesca Bruce
Canada Overhauls Drug Pricing, But Devil Will Be In The Detail
Long awaited changes to Canada’s Patented Medicines Regulations have been announced, but companies will have to wait for new guidelines from the pricing watchdog to better understand how they will be implemented.
Aspen Will Pay UK's NHS £8m In Landmark Deal Following Competition Probe
Aspen has agreed to pay the National Health Service £8m following an investigation by the Competition and Markets Authority.
Aspen to Pay UK NHS £8m In Landmark Deal Following Competition Probe
Aspen has agreed to pay the National Health Service £8m following an investigation by the Competition and Markets Authority.
Biogen Taken To Task Over Spinraza Price In Belgium & Italy
Excessive pricing is once again under the spotlight In Europe. Consumer rights organizations in Belgium and Italy have referred Biogen to the national competition authorities over “exorbitant pricing.”
Australian Reform Is Opportunity For International Work-Sharing On Non-Biological Complex Drugs
Plans to streamline the approval of generic medicines in Australia must include measures to ensure that safe and effective similar versions of non-biological complex medicines are available.